Klotho Neurosciences Inc (KLTO) is not a suitable buy for a beginner investor with a long-term strategy at this time. The stock shows signs of being overbought based on RSI, lacks positive financial performance, and has no significant trading or news catalysts to support a long-term investment decision. Additionally, there are no proprietary trading signals or options data to indicate a strong trading opportunity.

Technical Analysis

The MACD histogram is positive at 0.03 and expanding, indicating bullish momentum. However, the RSI is at 82.307, signaling the stock is overbought. Moving averages are converging, and the stock is trading near its resistance level (R1: 0.485). This suggests limited upside potential in the short term.

Positive Catalysts

NULL. No recent news, trading trends, or influential figure activity to act as a positive catalyst.

Neutral/Negative Catalysts

The stock appears overbought (RSI: 82.307). Financial performance is weak, with declining EPS (-72.22% YoY) and negative net income (-$2,895,585). There are no significant hedge fund or insider trading trends.

Financial Performance

In Q3 2025, revenue remained at $0 with no growth. Net income dropped to -$2,895,585 (-2.16% YoY), and EPS declined significantly to -0.05 (-72.22% YoY). Gross margin remained at 0%. Overall, the financials indicate poor performance and no growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast KLTO stock price to rise

Buy

Hold

Sell

Current: 0.532

Low

Averages

High